Published in Brain Res on February 19, 1993
Enhancing exposure-based therapy from a translational research perspective. Behav Res Ther (2007) 1.24
Augmentation treatment of psychotherapy for anxiety disorders with D-cycloserine. CNS Drug Rev (2007) 1.22
D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial. Neuropsychopharmacology (2013) 1.18
Once-weekly D-cycloserine effects on negative symptoms and cognition in schizophrenia: an exploratory study. Schizophr Res (2008) 1.04
Cognitive enhancers for facilitating drug cue extinction: insights from animal models. Pharmacol Biochem Behav (2011) 1.00
Protection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor. Br J Pharmacol (1999) 0.98
D-Cycloserine as an augmentation strategy for cognitive behavioral therapy of anxiety disorders. Biol Mood Anxiety Disord (2013) 0.98
Amantadine hydrochloride treatment in heredodegenerative ataxias: a double blind study. J Neurol Neurosurg Psychiatry (1996) 0.93
Does D-cycloserine enhance exposure therapy for anxiety disorders in humans? A meta-analysis. PLoS One (2014) 0.90
Pharmacological enhancement of drug cue extinction learning: translational challenges. Ann N Y Acad Sci (2011) 0.90
D-cycloserine to enhance extinction of cue-elicited craving for alcohol: a translational approach. Transl Psychiatry (2015) 0.81
Augmenting NMDA receptor signaling boosts experience-dependent neuroplasticity in the adult human brain. Proc Natl Acad Sci U S A (2015) 0.79
D-cycloserine augmentation of behavior therapy for anxiety and obsessive-compulsive disorders: A meta-analysis. PLoS One (2017) 0.75
Glutamatergic agents for OCD and related disorders. Curr Treat Options Psychiatry (2015) 0.75
D-cycloserine improves synaptic transmission in an animal mode of Rett syndrome. PLoS One (2017) 0.75
Neurological and neuropsychological consequences of electrical and lightning shock: review and theories of causation. Neural Regen Res (2017) 0.75
PDGF beta-receptor stimulates tyrosine phosphorylation of GAP and association of GAP with a signaling complex. Cell (1990) 4.85
Molecular cloning of two types of GAP complementary DNA from human placenta. Science (1988) 4.39
International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function. Pharmacol Rev (1998) 4.37
Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival. J Clin Invest (1986) 3.78
Phototransduction in transgenic mice after targeted deletion of the rod transducin alpha -subunit. Proc Natl Acad Sci U S A (2000) 3.72
Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med (1993) 3.61
Analysis of gene expression data using self-organizing maps. FEBS Lett (1999) 2.68
TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat Med (1998) 2.42
Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med (1988) 2.40
Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res (1992) 2.39
Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. Eur J Pharmacol (1990) 1.82
International consensus on (ICON) pediatric asthma. Allergy (2012) 1.79
Receptors for the age of anxiety: pharmacology of the benzodiazepines. Science (1980) 1.76
Randomized phase III study comparing Best Supportive Care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97-13. Int J Radiat Oncol Biol Phys (2000) 1.71
N-methyl-D-aspartate antagonists limit aminoglycoside antibiotic-induced hearing loss. Nat Med (1996) 1.69
Corneal response to orthokeratology. Optom Vis Sci (1998) 1.68
Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells. Oncogene (2011) 1.67
Differences in fear motivated behaviors among inbred mouse strains. Psychopharmacology (Berl) (1993) 1.67
Transient reversion of ras oncogene-induced cell transformation by antibodies specific for amino acid 12 of ras protein. Nature (1985) 1.61
Control of phenotypic expression of cultured melanoma cells by melanocyte stimulating hormones. Nat New Biol (1973) 1.60
Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure. N Engl J Med (1991) 1.59
Tamoxifen use in breast cancer patients who subsequently develop corpus cancer is not associated with a higher incidence of adverse histologic features. Gynecol Oncol (1994) 1.55
A selective imidazobenzodiazepine antagonist of ethanol in the rat. Science (1986) 1.53
The COOH-terminal domain of the Rap1A (Krev-1) protein is isoprenylated and supports transformation by an H-Ras:Rap1A chimeric protein. Mol Cell Biol (1991) 1.52
Zinc finger domains and phorbol ester pharmacophore. Analysis of binding to mutated form of protein kinase C zeta and the vav and c-raf proto-oncogene products. J Biol Chem (1994) 1.49
Ethanol stimulates gamma-aminobutyric acid receptor-mediated chloride transport in rat brain synaptoneurosomes. Proc Natl Acad Sci U S A (1986) 1.45
Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia. Carcinogenesis (1991) 1.43
Perinatal outcomes of a large cohort of extremely low gestational age infants (twenty-three to twenty-eight completed weeks of gestation). J Pediatr (1994) 1.42
Molecular biology of pigment cells. Molecular controls in mammalian pigmentation. Yale J Biol Med (1973) 1.39
Impact of modernising medical careers on operative training in otolaryngology. Clin Otolaryngol (2010) 1.38
Melanocyte-stimulating hormone promotes activation of pre-existing tyrosinase molecules in Cloudman S91 melanoma cells. Nature (1975) 1.36
Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones. Mol Pharmacol (2003) 1.35
Intra- and interstrain differences in models of "behavioral despair". Pharmacol Biochem Behav (2001) 1.31
Determination and analysis of adenovirus-2 DNA sequences which may include signals for late messenger RNA processing. J Mol Biol (1979) 1.28
Increasing email consultations may marginalise more people. BMJ (2001) 1.25
Prevalence of asthma and allergy in Hong Kong schoolchildren: an ISAAC study. Eur Respir J (1997) 1.24
Interleukin 1 regulates human metallothionein gene expression. Mol Cell Biol (1985) 1.23
Comparison of the ISAAC video questionnaire (AVQ3.0) with the ISAAC written questionnaire for estimating asthma associated with bronchial hyperreactivity. Clin Exp Allergy (1997) 1.20
Identification of inosine and hypoxanthine as endogenous inhibitors of [3H] diazepam binding in the central nervous system. Life Sci (1978) 1.20
A UK national audit of hereditary and acquired angioedema. Clin Exp Immunol (2014) 1.19
Quality of life of women with ovarian cancer. Gynecol Oncol (1995) 1.19
Antidepressant-like actions of an AMPA receptor potentiator (LY392098). Neuropharmacology (2001) 1.19
Immunological variables as predictors of prognosis in patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome. Cancer Res (1986) 1.17
Separation of parathyroid hormone and calcitonin-sensitive cells from non-responsive bone cells. Nature (1974) 1.17
Prodromes, coping strategies, insight and social functioning in bipolar affective disorders. Psychol Med (1997) 1.16
Characterization of benzodiazepine binding sites in cultured cells of neural origin. J Neurochem (1979) 1.14
Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid. J Pharmacol Exp Ther (1993) 1.13
Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol (2002) 1.11
A rapid and sensitive radioreceptor assay for benzodiazepine in plasma. Arch Gen Psychiatry (1979) 1.11
Skin cancer prevention: a possible role of 1,25dihydroxyvitamin D3 and its analogs. J Steroid Biochem Mol Biol (2005) 1.10
Single-dose toxicity study of hepatic intra-arterial infusion of doxorubicin coupled to a novel magnetically targeted drug carrier. Toxicol Sci (2001) 1.08
Pain in ovarian cancer patients. Prevalence, characteristics, and associated symptoms. Cancer (1994) 1.08
PS1 N- and C-terminal fragments form a complex that functions in APP processing and Notch signaling. Proc Natl Acad Sci U S A (2001) 1.07
Interleukin 4 is at 5q31 and interleukin 6 is at 7p15. Hum Genet (1988) 1.05
The acupuncture treatment of low back pain: a randomized controlled study. Am J Chin Med (1980) 1.05
Response of mouse melanoma cells to melanocyte stimulating hormone. Nature (1974) 1.05
Benzodiazepine receptor-mediated experimental "anxiety" in primates. Science (1982) 1.05
Measuring short-term gamma-irradiation effects on mouse salivary gland function using a new saliva collection device. Arch Oral Biol (2001) 1.04
Antibodies specific for amino acid 12 of the ras oncogene product inhibit GTP binding. Proc Natl Acad Sci U S A (1985) 1.04
Rapid changes in brain benzodiazepine receptors after experimental seizures. Science (1978) 1.03
Selective anxiolysis produced by ocinaplon, a GABA(A) receptor modulator. Proc Natl Acad Sci U S A (2005) 1.03
Chronic administration of imipramine and citalopram alters the expression of NMDA receptor subunit mRNAs in mouse brain. A quantitative in situ hybridization study. J Mol Neurosci (1998) 1.02
Prodromes, coping strategies and course of illness in bipolar affective disorder--a naturalistic study. Psychol Med (2001) 1.00
Does local anaesthetic affect the success rate of intravenous cannulation? Anaesth Intensive Care (1999) 1.00
Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715). Pharmacol Biochem Behav (1995) 1.00
The NMDA antagonist memantine blocks the expression and maintenance of morphine dependence. Pharmacol Biochem Behav (1996) 1.00
Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: clinical correlations. Blood (1991) 1.00
Developing a tobacco survey for deaf youth. Am Ann Deaf (2000) 1.00
Truncated trkB.T1 is dominant negative inhibitor of trkB.TK+-mediated cell survival. Biochem Biophys Res Commun (2001) 1.00
Stimulation of human hematopoietic colony formation by recombinant gibbon multi-colony-stimulating factor or interleukin 3. J Clin Invest (1987) 0.99
Kaposi's sarcoma and the acquired immune deficiency syndrome. Treatment with recombinant interferon alpha and analysis of prognostic factors. Cancer (1986) 0.99
Regulation of BDNF expression in primary neuron culture by LY392098, a novel AMPA receptor potentiator. Neuropharmacology (2001) 0.98
Transgenic mice overexpressing truncated trkB neurotrophin receptors in neurons have impaired long-term spatial memory but normal hippocampal LTP. Synapse (2000) 0.98
Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments. J Pharmacol Exp Ther (1994) 0.98
Convulsant potencies of tetrazoles are highly correlated with actions on GABA/benzodiazepine/picrotoxin receptor complexes in brain. Life Sci (1984) 0.98
The acupuncture treatment of neck pain: a randomized controlled study. Am J Chin Med (1981) 0.97
Demonstration of an endogenous, competitive inhibitor(s) of [3H] diazepam binding in bovine brain. Life Sci (1978) 0.97
(2S,4R)-4-methylglutamic acid (SYM 2081): a selective, high-affinity ligand for kainate receptors. J Pharmacol Exp Ther (1997) 0.97
Geriatric hip fracture clinical pathway: the Hong Kong experience. Osteoporos Int (2010) 0.97
Reversal of the behavioral and electrophysiological abnormalities of an animal model of hepatic encephalopathy by benzodiazepine receptor ligands. Hepatology (1990) 0.97
Isoflurane anesthesia is stereoselective. Eur J Pharmacol (1992) 0.96
[3H]Threo-(+/-)-methylphenidate binding to 3,4-dihydroxyphenylethylamine uptake sites in corpus striatum: correlation with the stimulant properties of ritalinic acid esters. J Neurochem (1985) 0.96
Synthesis and pharmacological properties of novel 8-substituted imidazobenzodiazepines: high-affinity, selective probes for alpha 5-containing GABAA receptors. J Med Chem (1996) 0.96
Modeling the supply of nurse labor. Life-cycle activity patterns of registered nurses in one Canadian delivery system. Med Care (1986) 0.96
Adenosine and cyclic AMP in rat cerebral cortical slices: effects of adenosine uptake inhibitors and adenosine deaminase inhibitors. J Neurochem (1981) 0.95
The effect of dietary omega-3 fatty acids (fish oil) on azoxymethanol-induced focal areas of dysplasia and colon tumor incidence. Cancer (1990) 0.95
Stereospecific actions of the inhalation anesthetic isoflurane at the GABAA receptor complex. Brain Res (1993) 0.94
Benzodiazepine receptors in the central nervous system. Int Rev Neurobiol (1982) 0.94
The neuroprotective agent memantine induces brain-derived neurotrophic factor and trkB receptor expression in rat brain. Mol Cell Neurosci (2001) 0.94
Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response. Gynecol Oncol (1995) 0.93
Effects of CEES on inflammatory mediators, heat shock protein 70A, histology and ultrastructure in two skin models. J Appl Toxicol (2000) 0.93
[3H]ATPA: a high affinity ligand for GluR5 kainate receptors. Neuropharmacology (1999) 0.92
Neuropharmacological antagonism of the beta-carboline-induced "anxiety" response in rhesus monkeys. J Neurosci (1985) 0.92
Accuracy of clinical impressions and Mini-Mental State Exam scores for assessing capacity to consent to major medical treatment. Comparison with criterion-standard psychiatric assessments. Psychosomatics (1997) 0.92
Progressive fetal bronchial obstruction caused by a bronchogenic cyst diagnosed using prenatal MR imaging. AJR Am J Roentgenol (2001) 0.92
Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABAA-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure. Gastroenterology (1987) 0.92
Bone mineralization in women following successful treatment of Hodgkin's disease. Am J Med (1988) 0.91
Structure and expression of genes of GM-CSF and G-CSF in blast cells from patients with acute myeloblastic leukemia. Blood (1988) 0.91
Specific [3H] beta-phenylethylamine binding sites in rat brain. Eur J Pharmacol (1982) 0.91
Acute stress enhances the activity of the GABA receptor-gated chloride ion channel in brain. Brain Res (1987) 0.91